Breast cancer after childhood cancer: A report from the Childhood Cancer Survivor Study

Annals of Internal Medicine

Volumn 141, Issue 8, 2004, Pages 590-597

  Kenney, Lisa B ^a   Yasui, Yutaka ^b   Inskip, Peter D ^b   Hammond, Sue ^b   Neglia, Joseph P ^b   Mertens, Ann C ^b   Meadows, Anna T ^b   Friedman, Debra ^b   Robison, Leslie L ^b   Diller, Lisa ^b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; BREAST CARCINOMA; CANCER CYTODIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURVIVAL; CHILDHOOD CANCER; CLINICAL TRIAL; COHORT ANALYSIS; DISEASE ASSOCIATION; FAMILIAL CANCER; FAMILY HISTORY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MEDICAL ASSESSMENT; MENSTRUAL CYCLE; MULTICENTER STUDY; PATIENT INFORMATION; POPULATION RESEARCH; PRIORITY JOURNAL; RISK ASSESSMENT; SOFT TISSUE SARCOMA; SURVIVAL RATE; THYROID DISEASE; BREAST TUMOR; CHILD; GENETIC PREDISPOSITION; GENETICS; HODGKIN DISEASE; MIDDLE AGED; PATHOLOGY; RETROSPECTIVE STUDY; RISK FACTOR; SARCOMA; SECOND CANCER; SURVIVOR; TIME;

ADULT; BREAST NEOPLASMS; CHILD; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HODGKIN DISEASE; HUMANS; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; RETROSPECTIVE STUDIES; RISK FACTORS; SARCOMA; SURVIVORS; THYROID DISEASES; TIME FACTORS;

EID: 6044269466     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-141-8-200410190-00006     Document Type: Article

References (37)

1. Neglia JP, Friedman DL, Yasui Y, Mertens AC, Hammond S, Stovall M, et al. Second malignant neoplasms in five-year survivors of childhood cancer: childhood cancer survivor study. J Natl Cancer Inst. 2001;93:618-29. [PMID: 11309438]
2. Bhatia S, Robison LL, Oberlin O, Greenberg M, Bunin G, Fossati-Bellani F, et al. Breast cancer and other second neoplasms after childhood Hodgkin's disease. N Engl J Med. 1996;334:745-51. [PMID: 8592547]
3. van Leeuwen FE, Klokman WJ, Veer MB, Hagenbeek A, Krol AD, Vetter UA, et al. Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthood. J Clin Oncol. 2000;18:487-97. [PMID: 10653864]
4. Metayer C, Lynch CF, Clarke EA, Glimelius B, Storm H, Pukkala E, et al. Second cancers among long-term survivors of Hodgkin's disease diagnosed in childhood and adolescence. J Clin Oncol. 2000;18:2435-43. [PMID: 10856104]
5. Sankila R, Garwicz S, Olsen JH, Döllner H, Hertz H, Kreuger A, et al. Risk of subsequent malignant neoplasms among 1,641 Hodgkin's disease patients diagnosed in childhood and adolescence: a population-based cohort study in the five Nordic countries. Association of the Nordic Cancer Registries and the Nordic Society of Pediatric Hematology and Oncology. J Clin Oncol. 1996;14:1442-6. [PMID: 8622057]
6. Swerdlow AJ, Barber JA, Hudson GV, Cunningham D, Gupta RK, Hancock BW, et al. Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: the relation to age at treatment. J Clin Oncol. 2000;18:498-509. [PMID: 10653865]
7. Green DM, Hyland A, Barcos MP, Reynolds JA, Lee RJ, Hall BC, et al. Second malignant neoplasms after treatment for Hodgkin's disease in childhood or adolescence. J Clin Oncol. 2000;18:1492-9. [PMID: 10735897]
8. Hancock SL, Tucker MA, Hoppe RT. Breast cancer after treatment of Hodgkin's disease. J Natl Cancer Inst. 1993;85:25-31. [PMID: 8416252]
9. Aisenberg AC, Finkelstein DM, Doppke KP, Koerner FC, Boivin JF, Willett CG. High risk of breast carcinoma after irradiation of young women with Hodgkin's disease. Cancer. 1997;79:1203-10. [PMID: 9070499]
10. Ng AK, Bernardo MV, Weller E, Backstrand K, Silver B, Marcus KC, et al. Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: long-term risks and risk factors. Blood. 2002;100:1989-96. [PMID: 12200357]
11. Travis LB, Hill DA, Dores GM, Gospodarowicz M, van Leeuwen FE, Holowaty E, et al. Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease. JAMA. 2003;290:465-75. [PMID: 12876089]
12. van Leeuwen FE, Klokman WJ, Stovall M, Dahler EC, van't Veer MB, Noordijk EM, et al. Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin's disease. J Natl Cancer Inst. 2003;95:971-80. [PMID: 12837833]
13. Breslow NE, Takashima JR, Whitton JA, Moksness J, D'Angio GJ, Green DM. Second malignant neoplasms following treatment for Wilm's tumor: a report from the National Wilms' Tumor Study Group. J Clin Oncol. 1995;13:1851-9. [PMID: 7636528]
14. Scaradavou A, Heller G, Sklar CA, Ren L, Ghavimi F. Second malignant neoplasms in long-term survivors of childhood rhabdomyosarcoma. Cancer. 1995;76:1860-7. [PMID: 8625059]
15. Diller L, Medeiros Nancarrow C, Shaffer K, Matulonis U, Mauch P, Neuberg D, et al. Breast cancer screening in women previously treated for Hodgkin's disease: a prospective cohort study. J Clin Oncol. 2002;20:2085-91. [PMID: 11956269]
16. Wolden SL, Hancock SL, Carlson RW, Goffinet DR, Jeffrey SS, Hoppe RT. Management of breast cancer after Hodgkin's disease. J Clin Oncol. 2000;18:765-72. [PMID: 10673517]
17. Yahalom J, Petrek JA, Biddinger PW, Kessler S, Dershaw DD, McCormick B, et al. Breast cancer in patients irradiated for Hodgkin's disease: a clinical and pathologic analysis of 45 events in 37 patients. J Clin Oncol. 1992;10:1674-81. [PMID: 1403050]
18. Robison LL, Mertens AC, Boice JD, Breslow NE, Donaldson SS, Green DM, et al. Study design and cohort characteristics of the Childhood Cancer Survivor Study: a multi-institutional collaborative project. Med Pediatr Oncol. 2002;38:229-39. [PMID: 11920786]
19. National Cancer Institute. Surveillance, Epidemiology, and End Results (SEER) Program Public-Use CD-ROM (1973-1999). Bethesda, MD: National Cancel Institute, DCPC, Surveillance Program, Cancer Statistics Branch; April 2002.
20. Gooley TA, Leisenring W, Crowley J, Storer BE. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med. 1999;18:695-706. [PMID: 10204198]
21. Breslow NE, Day NE. Statistical Methods in Cancer Research, Volume II: The Design and Analysis of Cohort Studies. Lyon, France: International Agency for Research on Cancer; 1987. Scientific Publication no. 82.
22. Tucker MA, D'Angio GJ, Boice JD Jr, Strong LC, Li FP, Stovall M, et al. Bone sarcomas linked to radiotherapy and chemotherapy in children. N Engl J Med. 1987;317:588-93. [PMID: 3475572]
23. Gail MH, Brinton LA, Byar DP, Corle DK, Green SB, Schairer C, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst. 1989;81:1879-86. [PMID: 2593165]
24. Madigan MP, Ziegler RG, Benichou J, Byrne C, Hoover RN. Proportion of breast cancer cases in the United States explained by well-established risk factors. J Natl Cancer Inst. 1995;87:1681-5. [PMID: 7473816]
25. Byrne J, Fears TR, Gail MH, Pee D, Connelly RR, Austin DF, et al. Early menopause in long-term survivors of cancer during adolescence. Am J Obstet Gynecol. 1992;166:788-93. [PMID: 1550144]
26. MacKarem G, Roche CA, Hughes KS. The effectiveness of the Gail model in estimating risk for development of breast cancer in women under 40 years of age. Breast J. 2001;7:34-9. [PMID: 11348413]
27. Colditz GA, Rosner BA, Speizer FE. Risk factors for breast cancer according to family history of breast cancer. For the Nurses' Health Study Research Group. J Natl Cancer Inst. 1996;88:365-71. [PMID: 8609646]
28. Jernström H, Lerman C, Ghadirian P, Lynch HT, Weber B, Garber J, et al. Pregnancy and risk of early breast cancer in carriers of BRCA1 and BRCA2. Lancet. 1999;354:1846-50. [PMID: 10584720]
29. Varley JM, Thorncroft M, McGown G, Appleby J, Kelsey AM, Tricker KJ, et al. A detailed study of loss of heterozygosity on chromosome 17 in tumours from Li-Fraumeni patients carrying a mutation to the TP53 gene. Oncogene. 1997;14:865-71. [PMID: 9047394]
30. Garber JE, Goldstein AM, Kantor AF, Dreyfus MG, Fraumeni JF Jr, Li FP. Follow-up study of twenty-four families with Li-Fraumeni syndrome. Cancer Res. 1991;51:6094-7. [PMID: 1933872]
31. Sklar C, Whitton J, Mertens A, Stovall M, Green D, Marina N, et al. Abnormalities of the thyroid in survivors of Hodgkin's disease: data from the Childhood Cancer Survivor Study. J Clin Endocrinol Metab. 2000;85:3227-32. [PMID: 10999813]
32. Boice JD Jr. Radiation and breast carcinogenesis. Med Pediatr Oncol. 2001; 36:508-13. [PMID: 11340604]
33. Helzlsouer KJ, Harris EL, Parshad R, Fogel S, Bigbee WL, Sanford KK Familial clustering of breast cancer: possible interaction between DNA repair proficiency and radiation exposure in the development of breast cancer. Int J Cancer. 1995;64:14-7. [PMID: 7665242]
34. Li CI, Malone KE, Daling JR. Differences in breast cancer stage, treatment, and survival by race and ethnicity. Arch Intern Med. 2003;163:49-56. [PMID: 12523916]
35. Dawson LA, Chow E, Goss PE. Evolving perspectives in contralateral breast cancer. Eur J Cancer. 1998;34:2000-9. [PMID: 10070301]
36. Friedmann AM, Hudson MM, Weinstein HJ, Donaldson SS, Kun L, Tarbell NJ, et al. Treatment of unfavorable childhood Hodgkin's disease with VEPA and low-dose, involved-field radiation. J Clin Oncol. 2002;20:3088-94. [PMID: 12118022]
37. Donaldson SS, Hudson MM, Lamborn KR, Link MP, Kun L, Billett AL, et al. VAMP and low-dose, involved-field radiation for children and adolescents with favorable, early-stage Hodgkin's disease: results of a prospective clinical trial. J Clin Oncol. 2002;20:3081-7. [PMID: 12118021]